Overview

Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The aim of our study is to Estimate the reduction of LDL by ezetimibe in hypercholesterolemic patients on simvastatin.Investigate the effect of LDL lowering by ezetimibe on platelet activity and LDL tendency to peroxidation in hypercholesterolemic patients on simvastatin therapy The hypothesis is that: 1. LDL lowering by ezetimibe on-top of simvastatin in patients on fixed dose of simvastatin can reduce platelet aggregation, due to the potential decreasing of cholesterol content in the platelet membranes. 2. LDL lowering by ezetimibe can lower LDL tendency to peroxidation.
Phase:
Phase 4
Details
Lead Sponsor:
Ziv Hospital
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Simvastatin